May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Efficacy of the Baerveldt–250mm2 Glaucoma Implant Compared to the Ahmed S2 Glaucoma Valve
R.J. Goulet, III; D. WuDunn; L.B. Cantor; A.–D. Phan; J.T. Lind; A. Cortes; B. Wu
Author Affiliations & Notes
  • R.J. Goulet, III
    Ophthalmology, Indiana University School of Medicine, Indianapolis, IN
  • D. WuDunn
    Ophthalmology, Indiana University School of Medicine, Indianapolis, IN
  • L.B. Cantor
    Ophthalmology, Indiana University School of Medicine, Indianapolis, IN
  • A.–D. Phan
    Ophthalmology, Indiana University School of Medicine, Indianapolis, IN
  • J.T. Lind
    Ophthalmology, Indiana University School of Medicine, Indianapolis, IN
  • A. Cortes
    Ophthalmology, Indiana University School of Medicine, Indianapolis, IN
  • B. Wu
    Ophthalmology, Indiana University School of Medicine, Indianapolis, IN
  • Footnotes
    Commercial Relationships  R.J. Goulet, None; D. WuDunn, Pfizer, C; Pfizer, R; L.B. Cantor, AMO, C; AMO, R; A. Phan, None; J.T. Lind, None; A. Cortes, None; B. Wu, None.
  • Footnotes
    Support  Unrestricted departmental Research to Prevent Blindness grant
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 5490. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Efficacy of the Baerveldt–250mm2 Glaucoma Implant Compared to the Ahmed S2 Glaucoma Valve
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      R.J. Goulet, III, D. WuDunn, L.B. Cantor, A.–D. Phan, J.T. Lind, A. Cortes, B. Wu; Efficacy of the Baerveldt–250mm2 Glaucoma Implant Compared to the Ahmed S2 Glaucoma Valve . Invest. Ophthalmol. Vis. Sci. 2006;47(13):5490.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : To compare the efficacy and safety of the Baerveldt–250mm2 Glaucoma Implant and the Ahmed S2 Glaucoma Valve in the treatment of adult glaucoma.

Methods: : Retrospective, comparative, interventional case series consisting of 169 patients who received either the Baerveldt–250mm2 Glaucoma Implant (111 eyes of 111 patients) or the Ahmed S2 Glaucoma Valve (58 eyes of 58 patients) by the IU Glaucoma Service from 1996 to 2002. Eyes that had previous drainage implant procedures were excluded from both groups. If both eyes of a single patient received an implant, the second eye to undergo implantation was excluded from the study. Main outcome measures included intraocular pressure (IOP), visual acuity, number of glaucoma medications, and surgical complications. Success was defined as IOP > 5 mmHg and < 22 mmHg (with or without anti–glaucoma medications), and without further glaucoma surgery, devastating complication (i.e. suprachoroidal hemorrhage, retinal detachment), or loss of light perception attributable to drainage implantation.

Results: : The two groups were similar with regards to age, gender, race, NVG diagnosis, number of prior ocular surgeries, preoperative IOP, and number of preoperative glaucoma medications. Mean duration of follow–up was 22.4 months for Baerveldt eyes and 19.2 months for Ahmed eyes. At last follow–up visit, eyes in the Baerveldt group had significantly lower mean IOP (15.8 ± 7.5 vs. 19.8 ± 9.6 mmHg, p=0.004, t test) and fewer anti–glaucoma medications (0.8 ± 1.0 vs. 1.4 ± 1.2 medications, p=0.003, Mann–Whitney) than eyes in the Ahmed group. Although Kaplan–Meier survival was slightly better for Baerveldt eyes, the difference was not statistically significant. For all eyes, preoperative IOP was a significant predictor of eventual failure (HR: 1.03 per mmHg, p=0.004, Cox Proportional Hazard).

Conclusions: : The Baerveldt–250mm2 Glaucoma Implant and the Ahmed S2 Glaucoma Valve are effective drainage implant options that may be used in the treatment of adult refractory glaucoma. Both devices control IOP and exhibit similar surgical outcomes. Our study suggests that the Baerveldt–250mm2 device may be more effective at lowering intraocular pressure. Regardless of the device used, preoperative IOP is a risk factor for eventual failure.

Keywords: intraocular pressure • clinical (human) or epidemiologic studies: outcomes/complications 
© 2006, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept